Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study
Fumihiko Urabe(Jikei University School of Medicine), Takaya Sasaki(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Naoki Uchida(SHOWA Medical University), Yuhei Koike(Jikei University School of Medicine), Kojiro Tashiro(Jikei University School of Medicine), Sotaro Kayano(Jikei University Kashiwa hospital), Shuhei Hara(Jikei University School of Medicine), Takashi Ohtsuka(Keio University), Yu Imai(Jikei University School of Medicine), Koichi Aikawa(Jikei University School of Medicine), Minoru Nakazono(Jikei University School of Medicine), Mahito Atsuta(Jikei University Kashiwa hospital), Takahiro Kimura(Jikei University School of Medicine), Hirokazu Kagawa(Jikei University School of Medicine), Katsuki Muramoto(Jikei University School of Medicine), Yuma Goto(Jikei University School of Medicine), Mimu Ishikawa(Jikei University School of Medicine), Jun Miki(Jikei University Kashiwa hospital)
Cited by 6
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
|Experimental & Molecular Medicine|2019|112
Extracellular vesicles in the development of organ‐specific metastasis
|Journal of Extracellular Vesicles|2021|101